Hydroxynorketamines: pharmacology and potential therapeutic applications

JN Highland, P Zanos, LM Riggs, P Georgiou… - Pharmacological …, 2021 - ASPET
Hydroxynorketamines (HNKs) are formed in vivo after (R, S)-ketamine (ketamine)
administration. The 12 HNK stereoisomers are distinguished by the position of cyclohexyl …

Ketamine: a versatile tool for anesthesia and analgesia

W Barrett, M Buxhoeveden… - Current Opinion in …, 2020 - journals.lww.com
Ketamine is regaining popularity in the field of anesthesia and beyond. New studies provide
insight on the many indications and use that anesthesia providers may encounter during …

Target deconvolution studies of (2R, 6R)-hydroxynorketamine: an elusive search

J Bonaventura, JL Gomez, ML Carlton, S Lam… - Molecular …, 2022 - nature.com
The off-label use of racemic ketamine and the FDA approval of (S)-ketamine are promising
developments for the treatment of depression. Nevertheless, racemic ketamine and (S) …

Molecular pharmacology and neurobiology of rapid-acting antidepressants

TD Gould, CA Zarate Jr… - Annual review of …, 2019 - annualreviews.org
For decades, symptoms of depression have been treated primarily with medications that
directly target the monoaminergic brain systems, which typically take weeks to exert …

Nanocrystals Slow-Releasing Ropivacaine and Doxorubicin to Synergistically Suppress Tumor Recurrence and Relieve Postoperative Pain

F Peng, J Liu, J Chen, W Wu, Y Zhang, G Zhao… - ACS …, 2023 - ACS Publications
Although surgical resection provides a straightforward and effective treatment for most
malignant solid tumors, tumor recurrence and acute postoperative pain continue to be two …

Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression

CA Farmer, JR Gilbert, R Moaddel, J George… - …, 2020 - nature.com
A single, subanesthetic dose of (R, S)-ketamine (ketamine) exerts rapid and robust
antidepressant effects. Several groups previously reported that (2S, 6S; 2R, 6R) …

Narrative review: low-dose ketamine for Pain Management

A Riccardi, M Guarino, S Serra… - Journal of Clinical …, 2023 - mdpi.com
Pain is the leading cause of medical consultations and occurs in 50–70% of emergency
department visits. To date, several drugs have been used to manage pain. The clinical use …

Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine

JN Highland, PJ Morris, P Zanos… - Journal of …, 2019 - journals.sagepub.com
Background:(R, S)-ketamine has gained attention for its rapid-acting antidepressant actions
in patients with treatment-resistant depression. However, widespread use of ketamine is …

The potent analgesia of intrathecal 2R, 6R-HNK via TRPA1 inhibition in LF-PENS-induced chronic primary pain model

AR Liu, ZJ Lin, M Wei, Y Tang, H Zhang… - The Journal of …, 2023 - Springer
Background Chronic primary pain (CPP) is an intractable pain of unknown cause with
significant emotional distress and/or dysfunction that is a leading factor of disability globally …

Ketamine in the past, present, and future: mechanisms, metabolites, and toxicity

ES Schwenk, B Pradhan, R Nalamasu, L Stolle… - Current pain and …, 2021 - Springer
Abstract Purpose of Review While ketamine's analgesia has mostly been attributed to
antagonism of N-methyl-d-aspartate receptors, evidence suggests multiple other pathways …